Aa. Aljafari, KINETICS FOR THE INHIBITION OF ACETYLCHOLINESTERASE FROM HUMAN ERYTHROCYTE BY CISPLATIN, International journal of biochemistry & cell biology, 27(9), 1995, pp. 965-970
The antitumor drug cisplatin causes neurological side-effects in patie
nts treated with this drug. Since acetylcholine plays a key role in hu
man neurotransmission we characterized the inhibitory effect of cispla
tin on the enzyme, acetylcholinesterase. Enzyme activity was monitored
spectrophotometrically using Ellman's method. The time for 50% inhibi
tion (t(1/2)) was inversely proportional to the concentration of the c
isplatin. The reaction was therefore assessed to have a bimolecular ra
te constant of 36.5 (mM min)(-1). The K-m and V-max were both decrease
d by 45 and 48%, respectively by 7.0 mM cisplatin during the reversibl
e phase while the K-m was increased 138% and V-max was decreased up to
65% in the irreversible phase. The nature of the inhibition was uncom
petitive and complex irreversible at the reversible and irreversible s
tages respectively, The inhibition constants for reversible and irreve
rsible steps were estimated as 1.12 mM and 97.70 (mM min)(-1) respecti
vely, The dissociation constant for the irreversible complex was 2.62
mM. These studies show that cisplatin is an uncompetitive inhibitor of
acetylcholinesterase. Such effects may contribute, at least in part,
to the neurotoxic effects associated with the use of cisplatin.